Webinar

Webinar

Post-Election Insights: What’s Next for the 340B Program?

With the election behind us, the healthcare industry is buzzing with questions about the future of the 340B Drug Pricing Program.

Here’s what we’ll cover:

  • Election Recap and Legislative Outlook: What do the election results mean for 340B? Can Congress make progress, and where does a GOP-controlled government stand on the program? We’ll also revisit how the first Trump administration handled 340B and discuss what could happen next.
  • 340B on State Ballots: Did you hear about California’s Proposition 34? For the first time, 340B appeared on a state ballot. We’ll explore what this means for California and the potential for similar measures in other states.
  • The Future of HHS Leadership: New leadership at Health & Human Services could reshape how HRSA oversees the 340B program. We’ll discuss the top candidates and what their appointments could mean for the program’s future.
  • John Thune and the SUSTAIN 340B Act: As the newly elected Senate Majority Leader, John Thune is a longtime supporter of the 340B program. We’ll dive into the SUSTAIN 340B Act, which he sponsors, and discuss its potential to improve transparency, clarify contract pharmacy networks, and more.
  • Wider Healthcare Impacts:Thune is also a strong advocate for telehealth, rural healthcare, and holding pharmacy benefit managers (PBMs) accountable. We’ll explore how these priorities could drive broader healthcare reforms.

Presented By

ANTHONY VELASQUEZ
Chief Product Officer